Apomorphine
( DrugBank: Apomorphine / KEGG DRUG: Apomorphine hydrochloride, Apomorphine )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 5 | Progressive supranuclear palsy | 1 |
| 6 | Parkinson disease | 66 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 7 | Corticobasal degeneration | 1 |
5. Progressive supranuclear palsy
Clinical trials : 120 / Drugs : 141 - (DrugBank : 36) / Drug target genes : 68 - Drug target pathways : 112
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
6. Parkinson disease
Clinical trials : 2,817 / Drugs : 2,606 - (DrugBank : 348) / Drug target genes : 185 - Drug target pathways : 205
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
7. Corticobasal degeneration
Clinical trials : 28 / Drugs : 55 - (DrugBank : 14) / Drug target genes : 9 - Drug target pathways : 42
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|